Psoriatic Arthritis Market Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

Posted on
by

Psoriatic Arthritis Market Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market
Psoriatic Arthritis Market
DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Psoriatic Arthritis market report provides current treatment practices, emerging drugs, Psoriatic Arthritis market share of the individual therapies, and current and forecasted Psoriatic Arthritis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Psoriatic Arthritis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Psoriatic Arthritis market.

Some of the key facts of the Psoriatic Arthritis  Market Report:

  •  As per DelveInsight’s assessments in 2021, analysts showed that in the United States, there were approximately 333,000 moderate cases, close to 155,500 severe cases, and nearly 62,000 mild cases of PsA
  •  As per DelveInsight’s assessments in 2021, analysts showed that in the United States, there were approximately 333,000 moderate cases, close to 155,500 severe cases, and nearly 62,000 mild cases of PsA
  •  The highest cases of PsA were found in the age group 50–59 years, and the least number of cases were observed in the 18–29 age group in the 7MM. For example, in 2021, more than 17,800 cases were observed in the 50–59 age group and about 5,400 cases in the age group 18–29 in Japan

 

Key benefits of the Psoriatic Arthritis  Market report:

 

  • The report covers the descriptive overview of Psoriatic Arthritis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  •  Comprehensive insight has been provided into the Psoriatic Arthritis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Psoriatic Arthritis is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  •  A detailed review of the Psoriatic Arthritis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Psoriatic Arthritis market

Got queries? Click here to know more about the Psoriatic Arthritis Market Landscape

Psoriatic Arthritis  Market Overview

The Psoriatic Arthritis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Psoriatic Arthritis market trends by analyzing the impact of current Psoriatic Arthritis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

 

This segment gives a thorough detail of Psoriatic Arthritis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Psoriatic Arthritis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

According to DelveInsight, the Psoriatic Arthritis market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Psoriatic Arthritis  Market Epidemiological Insight

 

The Psoriatic Arthritis epidemiology section provides insights about the historical and current Psoriatic Arthritis patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Psoriatic Arthritis market report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 

 

  • According to DelveInsight’s analysts, in 2021, the total diagnosed cases of PsA in the US were approximately 551,000 cases, and more than 680,000 cases in the EU-5, which are expected to rise during the forecast period (2022–2032).According to DelveInsight analysis, the total diagnosed cases of PsA were highest in Spain (about 192,000 cases) among the EU-5, which are expected to increase during the forecast period (2022–2032).In 2021, the total prevalent cases of PsA in the 7MM were more than 1,400,000, of which the highest cases were observed in the United States (~650,000 cases). The EU-5 countries accounted for nearly 750,000 prevalent cases, and Japan had approximately 73,000  cases in 2021.

Psoriatic Arthritis  Market Epidemiological  Segmentation 

 

  • Psoriatic Arthritis total diagnosed cases 
  • Psoriatic Arthritis severity-specific cases 
  •  Psoriatic Arthritis gender-specific cases 
  • Psoriatic Arthritis total prevalent cases 

Psoriatic Arthritis  Market Outlook 

The Psoriatic Arthritis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Psoriatic Arthritis market trends by analyzing the impact of current Psoriatic Arthritis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

 

This segment gives a thorough detail of Psoriatic Arthritis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Psoriatic Arthritis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

According to DelveInsight, the Psoriatic Arthritis market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Learn more by requesting for sample @Psoriatic Arthritis Market Landscape

Psoriatic Arthritis Key Companies  

  • Sun Pharma
  • Bristol-Myers Squibb
  • UCB Biopharma
  • And others

Psoriatic Arthritis Therapies 

  •  ILUMYA
  •  Deucravacitinib
  •  Bimekizumab
  • And others.

 

Table of Contents

  •  Key Insights 
  •  Report Introduction 
  • Executive Summary of Psoriatic Arthritis  
  •  Disease Background and Overview
  • Epidemiology and patient population
  • The United States 
  •  EU 5
  •  Psoriatic Arthritis  Emerging Therapies
  •  Psoriatic Arthritis Market Outlook
  •  Market Access and Reimbursement of Therapies
  • Appendix
  •  Psoriatic Arthritis  Report Methodology
  •  DelveInsight Capabilities
  • Disclaimer
  •  About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/